Reuters logo
BRIEF-Radius Health says positive Phase I data for investigational drug RAD1901
December 8, 2016 / 2:15 PM / a year ago

BRIEF-Radius Health says positive Phase I data for investigational drug RAD1901

Dec 8 (Reuters) - Radius Health Inc

* Radius presents positive Phase I data for investigational drug RAD1901 at the San Antonio Breast Cancer Symposium (SABCS) 2016

* Radius Health Inc - RAD1901 was well-tolerated with most common adverse events being low grade nausea and dyspepsia Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below